The content on this site is intended for healthcare professionals only
What is the role of autologous stem cell transplant in multiple myeloma?
First results of the GMMG-CONCEPT trial for multiple myeloma
Iberdomide in combination with dexamethasone for multiple myeloma
PLEIADES: Daratumumab combinations for multiple myeloma
Treatment options for high risk relapsed/refractory multiple myeloma
Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multiple myeloma
BCMA: A new biomarker for multiple myeloma
ICARIA: Isatuximab, pomalidomide and dexamethasone in relapsed/refractory multiple myeloma
BELLINI: Venetoclax or placebo with bortezomib and dexamethasone for relapsed/refractory multiple myeloma
Transitioning from bortezomib to ixazomib in patients with multiple myeloma
Implementing national cancer control plans
The changing landscape of AML
